Exchange: NASDAQ·Updated 07:58 PM EDT

ACB News

News
all
press releases
Aurora Cannabis Provides Business Update; Accretive Acquisition of Safari Flower Company and Leading European Performance Expected to Fuel International Growth in the Fiscal Second Quarter 2027 and Beyond
Aurora Cannabis Provides Business Update; Accretive Acquisition of Safari Flower Company and Leading European Performance Expected to Fuel International Growth in the Fiscal Second Quarter 2027 and Beyond Aurora Cannabis Provides Business Update; Accretive Acquisition of Safari Flower Company and...
PR Newswire
More News
Aurora Cannabis Refutes Curaleaf's Latest Attempt To Distract Shareholders From The Facts
Aurora Cannabis Refutes Curaleaf's Latest Attempt To Distract Shareholders From The Facts Aurora Cannabis Refutes Curaleaf's Latest Attempt To Distract Shareholders From The FactsPR NewswireEDMONTON, AB, Sept. 14, 2026 NASDAQ | TSX: ACBCuraleaf's announcement is a desperate effort to shift...
PR Newswire
TLRY Stock Loses 17% in Three Months: Should You Buy, Hold or Sell?
Tilray's revenues and EBITDA are growing, but weak margins, negative cash flow and competition raise questions about its next move.
Zacks
Aurora Cannabis Fires Back at Curaleaf's Hostile Takeover Bid
Aurora Cannabis urges shareholders to reject Curaleaf's unsolicited hostile bid, calling the offer undervaluation with serious risks.read more...
Benzinga
Curaleaf Responds to Aurora Circular; Reaffirms Offer as the Best Path to Value Creation for Shareholders
Curaleaf Responds to Aurora Circular; Reaffirms Offer as the Best Path to Value Creation for Shareholders Curaleaf Responds to Aurora Circular; Reaffirms Offer as the Best Path to Value Creation for Shareholders PR Newswire STAMFORD, Conn., Sept. 2, 2026 HighlightsCuraleaf Offers a 45% Premium and...
PR Newswire
Cannabis Stock CRLBF Surges 10% in a Month: Time to Buy or Sell?
Cresco's 10% monthly rally reflects stronger revenues, organic growth and margins, but competition and normalization risks cloud the outlook.
Zacks
Aurora Cannabis Urges Shareholders to REJECT Curaleaf's Hostile Bid, Warning that it is Inadequate, Undervalues Aurora and Puts Shareholder Value and Future Upside at Risk
Aurora Cannabis Urges Shareholders to REJECT Curaleaf's Hostile Bid, Warning that it is Inadequate, Undervalues Aurora and Puts Shareholder Value and Future Upside at Risk Aurora Cannabis Urges Shareholders to REJECT Curaleaf's Hostile Bid, Warning that it is Inadequate, Undervalues Aurora and Puts...
PR Newswire
Is Aurora Cannabis Stock a Buy as Curaleaf Pushes a Hostile Takeover Bid?
Key PointsCuraleaf is offering Aurora shareholders $4 per share...
Nasdaq News: Markets
Cannabis Stock VRNO Rises 10% in a Month: Time to Buy, Hold or Sell?
Verano's rally follows strong Q2 results, but margin pressure and wider 2026 losses keep the stock in wait-and-watch mode.
Zacks
Curaleaf Rejects Aurora Defense, Reiterates $4 Premium Offer
In a statement on Monday, Curaleaf rejected Aurora’s assertions of inaccuracies in its unsolicited bid and accused the Canadian firm of using selective metrics to deflect from years of underperformance.
Stocktwits

Advertisement|Remove ads.